Northwest transfers to NASDAQ

Northwest Biotherapeutics Inc. (NASDAQ:NWBO) raised $12 million through the sale of 3 million shares at $4 in a follow-on underwritten by Aegis Capital and began trading on NASDAQ. Investors also received five-year warrants to purchase up to 1.5 million shares at $5. In June, Northwest said it planned to raise up to $28.8 million in the follow-on. In September, the company said it planned to switch to NASDAQ from OTCBB. ...